MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Magnetic resonance imaging(MRI)"

  • 2018 International Congress

    Diagnostic potential of automated middle cerebellar peduncle volumetry in variants of multiple system atrophy

    F. Krismer, K. Seppi, T. Potrusil, R. Steiger, I. Zucal, G. Göbel, G. Wenning, E. Gizewski, W. Poewe, C. Scherfler (Innsbruck, Austria)

    Objective: To include probabilistic information on the location of the middle cerebellar peduncle (MCP) into an existing subcortical segmentation atlas and to evaluate the diagnostic…
  • 2018 International Congress

    Cerebrospinal fluid flow dynamics in Huntington’s disease evaluated by phase contrast MRI

    F. Rodrigues, L. Byrne, E. De Vita, E. Johnson, N. Hobbs, J. Thornton, R. Scahill, E. Wild (London, United Kingdom)

    Objective: To elucidate the dynamics of CSF flow through the neuraxis in Huntington’s disease (HD) using phase contrast magnetic resonance imaging (PCMRI). Background: HD is…
  • 2018 International Congress

    Exploring novel diffusion-derived biomarkers in Parkinson’s disease Freezing of Gait

    B. Bluett, E. Bayram, S. Banks, Z. Mari, K. Sreenivasan, X. Zhuang, Z. Yang, C. Bird, D. Cordes, I. Litvan, V. Mishra (Las Vegas, NV, USA)

    Objective: To explore the association between novel diffusion-derived structural imaging biomarkers and disease duration in Parkinson’s disease with freezing of gait (PD-FOG). Background: Increasing free-water…
  • 2018 International Congress

    Discriminating Idiopathic PD Patients and Controls in PPMI Using Integrative Multi-Modal Neuroimaging Analysis with Graph Convolutions

    F. Wang, X. Zhang, L. He, C. Henchcliffe (New York, NY, USA)

    Objective: To discriminate Parkinson’s disease (PD) patients and controls in the Parkinson’s Progression Markers Initiative (PPMI) cohort according to MRI features using a novel a…
  • 2018 International Congress

    Brain Perfusion pattern linked to depressive state in Parkinson’s: An arterial spin labelling MRI study

    Y. Xing, S. Naidu, S. Schwarz, N. Bajaj, D. Auer (Nottingham, United Kingdom)

    Objective: To investigate patterns of cerebral blood flow alteration associated with depressive state in Parkinson’s disease (PD) by using principal component analysis of arterial spin…
  • 2018 International Congress

    Cortical thinning as a neuroimaging marker of cognitive decline in X-linked dystonia-parkinsonism

    J. Prasuhn, H. Hanßen, A. Domingo, C. Diesta, R. Rosales, R. Jamora, C. Klein, N. Brüggemann (Luebeck, Germany)

    Objective: To investigate whether alterations of cortical thickness correspond to cognitive dysfunction in XDP patients. Background: X-linked dystonia-parkinsonism (XDP) is a severe, hereditary movement disorder…
  • 2018 International Congress

    Quantitative Midbrain Measurement in Diagnosing Variants of Progressive Supranuclear Palsy

    H. Wang, YW. Zhang, J. Yuan, D. Xu, H. You, ML. Li, F. Feng (Beijing, China)

    Objective: To evaluate the effectiveness of quantitative midbrain measurements in differentiating vPSP from multiple system atrophy (MSA) and Parkinson’s disease (PD). Background: Newly published criteria…
  • 2018 International Congress

    Olfactory dysfunction, sleep disturbances, neuronal loss, and regional brain atrophy in an inducible mouse model of Alpha-Synucleinopathy

    E. Brison, S. Zehntner, A. Zijdenbos, K. Luk, B. Bedell (Montreal, QC, Canada)

    Objective: The objective of this work is to develop a unique mouse model of spreading α-synucleinopathy to accelerate the development of novel disease-modifying treatments for…
  • 2018 International Congress

    Semi-automated segmentation and quantification of the substantia nigra depigmentation in Parkinson’s disease – a multicentre case control MRI study in 284 participants

    Y. Xing, S. Schwarz, A. Martin-Bastida, L. Parkes, H. Abdul-Sapuan, S. Naidu, M. Silverdale, D. Grosset, P. Piccini, D. Burn, N. Bajaj, N. Pavese, D. Auer (Nottingham, United Kingdom)

    Objective: To provide a semi-automated segmentation and quantification method of the changes in the substantia nigra (SN) in Parkinson’s disease (PD) using neuromelanin (NM)-sensitive MRI…
  • 2018 International Congress

    Superior cerebellar peduncles atrophy of PSP on PADRE imaging; comparison with idiopathic PD

    S. Kakeda, M. Miyata, T. Yoneda, S. Ide, K. Okada, H. Adachi, Y. Korogi (Kitakyushu, Japan)

    Objective: The purpose of our study was to determine whether atrophy of Superior cerebellar peduncles (SCP) on phase-weighted magnetic resonance imaging technique (PADRE) was useful…
  • « Previous Page
  • 1
  • …
  • 54
  • 55
  • 56
  • 57
  • 58
  • …
  • 78
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
    • VIT-D and Tics Movement Disorder
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley